Carregant...
Safety of intravitreal injection of ranibizumab in early pregnancy: a series of three cases
PURPOSE: Ranibizumab is used in the treatment of choroidal neovascularization (CNV). Although systemic exposure to ranibizumab is low after ocular administration, its mechanism of action must be regarded as potentially teratogenic and embryo-fetotoxic. Women are advised to wait 3 months after the la...
Guardat en:
| Publicat a: | Eye (Lond) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5898875/ https://ncbi.nlm.nih.gov/pubmed/29350689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.305 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|